Also trades as: 0HI3.L (LSE) · $vol 0M
ARWR NASDAQ
Arrowhead Pharmaceuticals, Inc.
1W: -5.3%
1M: +2.1%
3M: +18.7%
YTD: +11.4%
1Y: +363.5%
3Y: +100.6%
5Y: +3.7%
$74.95
-0.59 (-0.78%)
Weekly Expected Move ±7.6%
$65
$71
$77
$83
$88
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026505
Institutions Holding
+68 vs prior
62.2%
Ownership
-9.92%
98
New
148
Increased
206
Reduced
107
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-12 | Lu Hongbo | director | S-Sale | 2,970 | $76.88 | $228K | Filing |
| 2026-04-23 | Hamilton James C | officer: chief medical officer | S-Sale | 10,000 | $75.00 | $750K | Filing |
| 2026-04-22 | Apel Daniel Joseph | officer: chief financial officer | S-Sale | 8,730 | $71.92 | $628K | Filing |
| 2026-04-22 | Apel Daniel Joseph | officer: chief financial officer | S-Sale | 1,157 | $70.45 | $82K | Filing |
| 2026-04-22 | Apel Daniel Joseph | officer: chief financial officer | S-Sale | 3,208 | $70.11 | $225K | Filing |
| 2026-01-06 | Apel Daniel Joseph | officer: chief financial officer | A-Grant/Award | 75,000 | $— | $0 | Filing |
| 2026-01-06 | Hamilton James C | officer: chief medical officer | A-Grant/Award | 75,000 | $— | $0 | Filing |
| 2026-01-06 | O'Brien Patrick | officer: coo | A-Grant/Award | 75,000 | $— | $0 | Filing |
| 2026-01-06 | O'Brien Patrick | officer: coo | G-Gift | 440 | $— | $0 | Filing |
| 2026-01-06 | O'Brien Patrick | officer: coo | G-Gift | 540 | $— | $0 | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 12,711 | $63.95 | $813K | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 14,792 | $63.01 | $932K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 13,451 | $62.96 | $847K | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 1,200 | $64.49 | $77K | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 309 | $68.00 | $21K | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 6,090 | $62.28 | $379K | Filing |
| 2026-01-05 | Hamilton James C | officer: chief medical officer | S-Sale | 4,625 | $61.24 | $283K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 46 | $68.00 | $3K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 2,336 | $64.04 | $150K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 5,873 | $62.91 | $369K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 900 | $62.25 | $56K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 600 | $61.12 | $37K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 313 | $68.00 | $21K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 6,164 | $62.23 | $384K | Filing |
| 2026-01-05 | O'Brien Patrick | officer: coo | S-Sale | 4,368 | $61.20 | $267K | Filing |
🏛️ Congressional Trades
1 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2023-01-31 | Daniel Goldman | House | Sell | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18,161,519 | $1.1B | -3,157,063 | 2026-03-31 | Filing |
| Avoro Capital Advisors LLC | 10,699,999 | $671M | +74,999 | 2026-03-31 | Filing |
| FMR LLC | 7,266,652 | $456M | +746,244 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7,146,136 | $448M | +7,146,136 | 2026-03-31 | Filing |
| STATE STREET CORP | 6,496,130 | $407M | +92,300 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,032,416 | $378M | +6,032,416 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 4,278,828 | $275M | +1,013,865 | 2026-03-31 | Filing |
| Invesco Ltd. | 3,280,647 | $206M | +2,732,889 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 1,739,923 | $109M | +62,401 | 2026-03-31 | Filing |
| NORTHERN TRUST CORP | 1,655,837 | $104M | +309,580 | 2026-03-31 | Filing |
| Siren, L.L.C. | 1,615,476 | $101M | +115,000 | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 1,436,990 | $90M | +156,544 | 2026-03-31 | Filing |
| UBS Group AG | 1,336,271 | $84M | +348,984 | 2026-03-31 | Filing |
| UBS AM, a distinct business unit of UBS | 1,330,996 | $83M | +70,616 | 2026-03-31 | Filing |
| Pictet Asset Management Holding SA | 1,273,266 | $80M | +244,530 | 2026-03-31 | Filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,192,085 | $75M | -161,634 | 2026-03-31 | Filing |
| Driehaus Capital Management LLC | 1,190,335 | $75M | -579,005 | 2026-03-31 | Filing |
| Fisher Asset Management, LLC | 1,113,568 | $70M | -198,159 | 2026-03-31 | Filing |
| BANK OF AMERICA CORP /DE | 1,064,455 | $67M | +442,426 | 2026-03-31 | Filing |
| Hood River Capital Management LLC | 1,056,534 | $66M | +1,056,534 | 2026-03-31 | Filing |